Toufigh Gordi,Ann Walls Olmsted,Hsiao Dee Lieu,Luiz Belardinelli
申请号：
US13333789
公开号：
US20120189538A1
申请日:
2011.12.21
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson—an adenosine A2A receptor agonist—to a human undergoing myocardial imaging in an amount sufficient to achieve at least a minimal increase in average coronary peak flow velocity.
